Circulating Von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality
Author:
Funder
ANR
AP-HP
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Clinical Biochemistry,Physiology
Link
https://link.springer.com/content/pdf/10.1007/s10456-020-09762-6.pdf
Reference46 articles.
1. Debuc B, Smadja DM (2020) Is COVID-19 a new hematologic disease? Stem Cell Rev Rep 10:15. https://doi.org/10.1007/s12015-020-09987-4
2. Libby P, Lüscher T (2020) COVID-19 is, in the end, an endothelial disease. Eur Heart J 41(32):3038–3044
3. Connors JM, Levy JH (2020) COVID-19 and its implications for thrombosis and anticoagulation. Blood 135(23):2033–2040
4. Khider L, Gendron N, Goudot G et al (2020) Curative anticoagulation prevents endothelial lesion in COVID-19 patients. J Thromb Haemost 18:2391
5. Tang N, Bai H, Chen X et al (2020) Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost 18:1520
Cited by 114 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. EFCAB4B (CRACR2A/Rab46) Genetic Variants Associated with COVID-19 Fatality;COVID;2024-07-15
2. Endothelial biomarkers (Von willebrand factor, BDCA3, urokinase) as predictors of mortality in COVID-19 patients: cohort study;BMC Pulmonary Medicine;2024-07-04
3. Implications of von Willebrand Factor in Inflammatory Bowel Diseases: Beyond Bleeding and Thrombosis;Inflammatory Bowel Diseases;2024-07-03
4. Molecular Research on Coronavirus: Pathogenic Mechanisms, Antiviral Drugs, and New Vaccines;International Journal of Molecular Sciences;2024-06-04
5. The Onset of Intussusceptive Angiogenesis in COVID-19 Patients Might Come from the Mobilization of Stem Cell Sub-Populations Expressing the Hemangioblast Marker CD143;Stem Cell Reviews and Reports;2024-05-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3